Soiken HoldingsTSE:2385 +1.46%56 Quick Ratio is 9.37 as of Dec. 2025, which is 85% above its 10-year median of 5.06. GuruFocus rates TSE:2385 with a GF Score™ of 56/100 and a GF Value™ of 円114.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,410 Biotechnology companies, Soiken Holdings ranks better than 73.9% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Soiken Holdings's quick ratio for the quarter that ended in Dec. 2025 was 9.37.
Soiken Holdings has a quick ratio of 9.37. It generally indicates good short-term financial strength.
The historical rank and industry rank for Soiken Holdings's Quick Ratio or its related term are showing as below:
TSE:2385'
s Quick Ratio Range Over the Past 10 Years
Min: 2.89 Med: 5.06 Max: 10.14
Current: 8.44
During the past 13 years, Soiken Holdings's highest Quick Ratio was 10.14. The lowest was 2.89. And the median was 5.06.
TSE:2385's Quick Ratio is ranked better than 73.9% of 1410
companies
in the Biotechnology industry
Industry Median: 3.6
vs TSE:2385: 8.44
Soiken Holdings (TSE:2385) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Soiken Holdings Quick Ratio Related Terms
Soiken Holdings Quick Ratio Historical Data
* Premium members only.
The historical data trend for Soiken Holdings's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2385 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Soiken Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soiken Holdings Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Soiken Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Soiken Holdings's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Soiken Holdings's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Soiken Holdings (TSE:2385) has a Quick Ratio of 9.37 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Soiken Holdings and its competitors. This is 85% above median its historical median of 5.06. Over the past decade, Soiken Holdings' Quick Ratio has ranged from 2.89 to 10.14. According to the industry distribution chart, Soiken Holdings ranks #368 out of 1410 companies in the Biotechnology industry, placing it in the top 26.1%.
Is Soiken Holdings' Quick Ratio too high?
Soiken Holdings' current Quick Ratio of 9.37 is 85% above median its 10-year median of 5.06. Over the past 10 years, this metric has ranged from a low of 2.89 to a high of 10.14. The Biotechnology industry median Quick Ratio is 3.60. Soiken Holdings' value of 9.37 is 160.3% above this industry median. Based on the distribution chart, Soiken Holdings ranks #368 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Soiken Holdings has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Soiken Holdings ranks #368 out of 1410 companies for Quick Ratio. This puts Soiken Holdings in the upper half of its industry. The industry median Quick Ratio is 3.60. Soiken Holdings' value of 9.37 is 160.3% above this benchmark. Historically, Soiken Holdings' own Quick Ratio has ranged from 2.89 to 10.14 over the past decade. While the company's 10-year median is 5.06 vs. the industry median of 3.60, Soiken Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Soiken Holdings's current Quick Ratio of 9.37 is 160.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Soiken Holdings and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Soiken Holdings's current Quick Ratio is 9.37, which is 85% above median its own 10-year median of 5.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円114.55, compared to a current price of 円209.00 — trading 82.5% above its estimated fair value. The current Quick Ratio is 9.37, which is 85% above median its 10-year median of 5.06 and 160.3% above the Biotechnology industry median of 3.60. Soiken Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Quick Ratio is 9.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soiken Holdings (TSE:2385) Overvalued in 2026?
Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued.
The current stock price of 円209.00 is trading 82.5% above its estimated GF Value™ of 円114.55.
GuruFocus considers Soiken Holdings to be Significantly Overvalued.
Key valuation signals for TSE:2385:
Quick Ratio: 9.37 (85% above median its 10-year median of 5.06)
GF Value™: 円114.55 vs. price of 円209.00 (82.5% above fair value)
Industry Position: 160.3% above the Biotechnology median (#368 of 1410)
No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
56GF Score
Get the complete analysis for TSE:2385
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2385 has been successfully added to your 
